Behavioral Health

Grief: normal vs prolonged grief disorder

Clinical Overview and When to Suspect Prolonged Grief Disorder

— Acute grief: intense yearning, sadness, intrusive memories, somatic disturbance in the first weeks to months

— Integrated (adapted) grief: emerges gradually as the loss is incorporated into the person's life narrative; pain persists but no longer dominates daily function

— DSM-5-TR criteria: death of a close other ≥12 months ago (≥6 months in children/adolescents) with persistent, pervasive grief response

— Core symptoms: intense yearning/longing for the deceased OR preoccupation with thoughts/memories of the deceased, occurring most days for ≥1 month

— Plus ≥3 of 8: identity disruption ("part of me died"), disbelief, avoidance of reminders, intense emotional pain, difficulty reintegrating, emotional numbness, meaninglessness, intense loneliness

— Clinically significant distress or functional impairment beyond cultural/religious norms

— Patient ≥12 months post-loss still unable to return to work, withdrawn, ruminating, idealizing the deceased, or making decisions ("I can't get rid of his clothes")

— Comorbid depression, PTSD, suicidal ideation, alcohol misuse

Board pearl: The single most important historical anchor distinguishing normal grief from PGD on the exam is the 12-month time threshold plus functional impairment — not the intensity of sadness. A widow weeping at 3 months has grief; the same widow unable to leave the house at 14 months has PGD.

Grief is the normative, expected response to bereavement — a universal human experience, not a disorder.

Prolonged Grief Disorder (PGD) entered DSM-5-TR in March 2022 and ICD-11 as a distinct diagnosis.

When to suspect on Step 3:

Epidemiology: ~4% of bereaved adults; higher after violent, sudden, or unexpected death, loss of a child, or close kinship

Risk factors: prior depression/anxiety, insecure attachment style, caregiver burden, lack of social support, financial strain

Presentation Patterns and Key History

— Waves ("pangs") of sorrow triggered by reminders, with intact reality testing

— Yearning, searching behavior, transient auditory/visual hallucinations of the deceased (culturally normative)

— Preserved self-esteem; guilt is focal ("I should have called") rather than global

— Capacity for positive emotion returns intermittently — laughter at memories, engagement with grandchildren

— Acceptance of permanence; ability to recall the deceased without disorganizing pain

— Re-engagement with roles, relationships, future planning

— "Frozen in time" — keeps the deceased's room untouched, talks about them in present tense at 18 months

— Identity erosion: "I don't know who I am without her"

— Avoidance of reminders or the opposite — compulsive proximity-seeking (sleeping with ashes, daily cemetery visits that displace other roles)

— Bitterness, anger at fate, survivor guilt

— Time since death and circumstances (sudden, violent, suicide, overdose → higher PGD risk)

— Relationship to deceased (spouse, child)

— Functional status: work, ADLs, sleep, appetite, hygiene

— Suicidal ideation — explicit "I want to be with him" statements

— Substance use, especially new or increased alcohol/benzodiazepine use

— Cultural and religious mourning practices (mandatory context)

— Pervasive anhedonia, worthlessness, psychomotor retardation → think major depressive disorder

— Re-experiencing, hyperarousal, nightmares of the death scene → think PTSD

Key distinction: In normal grief, self-esteem is preserved and dysphoria is wave-like around reminders. In MDD complicating bereavement, dysphoria is persistent, with global worthlessness and anhedonia untethered from cues of the deceased.

Normal acute grief (weeks to months):

Integrated grief (≥6–12 months in most):

Prolonged Grief Disorder presentation:

Key history questions Step 3 expects:

Red flags for non-grief pathology:

Physical Exam Findings and Mental Status Assessment

— Weight loss, poor grooming, fatigue may appear in both normal grief and PGD — degree and persistence matter

— In PGD: often disheveled at >12 months; in MDD: psychomotor slowing, flat affect

— Tachycardia and elevated BP can occur with acute grief surges (catecholamine response)

— "Broken heart" — screen for takotsubo cardiomyopathy in older bereaved patients with chest pain or dyspnea in first 30 days

— Sleep deprivation signs; check for dehydration and orthostasis in frail elders

— Mood: sad, yearning, bitter (PGD) vs. pervasively depressed/anhedonic (MDD)

— Affect: reactive in grief (brightens with positive memory); constricted/flat in MDD

— Thought content: preoccupation with deceased (grief/PGD) vs. global worthlessness/guilt (MDD); ruminations about the death event with intrusions (PTSD)

— Perceptions: transient sensory experiences of the deceased are normative across cultures; sustained complex hallucinations or delusions are not

— Cognition: attention/concentration mildly impaired in acute grief; frank cognitive decline suggests pseudodementia of depression or unmasked neurocognitive disorder

— Insight: usually preserved

— Passive ("I'd be better off with him") vs. active ideation, plan, intent, access to means

— Recent loss of spouse, especially older men in the first year, carries elevated completed-suicide risk

— Use Columbia Suicide Severity Rating Scale (C-SSRS) on the exam

Step 3 management: A bereaved 72-year-old man with new firearm purchase, alcohol escalation, and statements about reunion requires same-visit safety planning, lethal-means counseling (remove the gun), and consideration of psychiatric hospitalization — do not defer to outpatient follow-up.

Grief is a clinical (history + MSE) diagnosis — there are no pathognomonic physical findings, but the exam screens for danger and comorbidity.

General appearance:

Vital signs and somatic:

Mental status exam:

Suicide risk assessment is mandatory:

Diagnostic Workup — Screening Tools and Initial Evaluation

— PG-13-R (Prolonged Grief-13, Revised): 13-item scale aligned to DSM-5-TR criteria; gold standard for PGD screening

— Inventory of Complicated Grief (ICG): older, score ≥25 suggests pathologic grief

— Brief Grief Questionnaire (BGQ): 5-item primary care screen

— PHQ-9 for major depression (PGD and MDD coexist in 50–70%)

— GAD-7 for generalized anxiety

— PCL-5 for PTSD — especially after traumatic/violent/suicide loss

— AUDIT-C and substance use history

— C-SSRS for suicidality

— TSH — hypothyroidism mimics depressive symptoms and weight change

— CBC, CMP — anemia, electrolyte derangements, renal/hepatic dysfunction

— Vitamin B12, vitamin D in elders with fatigue and cognitive complaints

— HbA1c if appetite/weight changes

— Consider urine toxicology if new substance misuse suspected

— Chest pain in first 30 days post-loss → ECG and troponin to evaluate for takotsubo or ACS

— Routine neuroimaging, EEG, or specialty referral for diagnosis of grief itself

Board pearl: On Step 3, if a stem mentions a bereaved patient with fatigue, weight gain, cold intolerance, and depressed mood — check a TSH before labeling it grief or depression. Missed hypothyroidism is a classic distractor.

Grief itself is diagnosed clinically; the workup serves three purposes: (1) confirm PGD vs. normal grief, (2) screen for comorbid psychiatric disorders, (3) exclude medical mimics.

Validated screening instruments:

Comorbidity screens (high-yield to order in the same visit):

Medical/laboratory workup for differential:

Cardiac considerations in acute bereavement:

What you do not need:

Diagnostic Workup — Differentiating PGD from Overlapping Disorders

— PGD: yearning, preoccupation with the deceased, identity disruption — symptoms organized around the loss

— MDD: pervasive anhedonia, global worthlessness/guilt, suicidality, psychomotor change — symptoms not specifically tied to the deceased

— DSM-5-TR removed the bereavement exclusion: MDD can be diagnosed during bereavement if full criteria are met for ≥2 weeks

— PTSD core: re-experiencing the traumatic event (the death scene), hyperarousal, avoidance of trauma cues, negative cognitions about safety

— PGD core: re-experiencing the person (yearning, longing), avoidance of reminders that intensify pain of absence

— Both can co-occur after violent, sudden, or witnessed death

— Adjustment disorder: symptoms within 3 months of stressor, resolve within 6 months of stressor cessation

— PGD: ≥12-month threshold, specific grief phenotype

— Time-based threshold (≥12 months) is necessary but not sufficient

— Functional impairment and grief-specific symptom cluster required

— Structured interview (e.g., Traumatic Grief Inventory–Clinician Administered) where available

— Collateral history from family — corroborates duration and functional decline

— Document cultural context; some mourning practices (e.g., extended Shiva, anniversary observances) are normative and not pathological

Key distinction: Ask the patient: "When you think about your loss, what bothers you most?" Yearning for the person → PGD. Re-experiencing the death scene → PTSD. Feeling worthless and unable to feel pleasure in anything → MDD. These three answers map to three different first-line treatments.

PGD shares features with MDD, PTSD, and adjustment disorder; correctly parsing them drives management.

PGD vs. Major Depressive Disorder:

PGD vs. PTSD:

PGD vs. Adjustment Disorder with depressed mood:

Normal acute grief vs. PGD:

Confirmatory steps:

Risk Stratification and Management Logic

— Active suicidality, psychosis, inability to care for self → emergent psychiatric evaluation, possible hospitalization

— PGD with comorbid MDD/PTSD/SUD → integrated outpatient psychiatric care

— PGD alone → grief-targeted psychotherapy (first-line)

— Normal acute grief → supportive care, psychoeducation, no medication, no formal psychotherapy required

— High-risk features: violent/sudden/unexpected death, suicide or overdose loss, loss of a child, prior psychiatric history, low social support, caregiver burnout, financial precarity

— Offer early targeted prevention (e.g., grief counseling, support groups) but not prophylactic antidepressants

— PGD first-line: Complicated Grief Therapy (CGT) / Prolonged Grief Disorder Therapy (PGDT) — 16-session manualized psychotherapy; superior to interpersonal therapy and to medication alone in RCTs

— CBT for grief, internet-delivered CBT — alternatives with evidence

— MDD comorbid with grief → SSRI + psychotherapy

— PTSD comorbid with grief → trauma-focused CBT or EMDR; SSRI adjunct

— Benzodiazepines for grief — risk of dependence, falls, blunted emotional processing

— Routine antidepressants for uncomplicated grief — no benefit over placebo in trials

Step 3 management: For a patient meeting PGD criteria, the single best initial step is referral to grief-targeted psychotherapy (CGT/PGDT), not initiation of an SSRI. Medication is added only for comorbid MDD, PTSD, or anxiety — not for PGD itself.

Step 1 — Triage: Is this normal grief, PGD, or a comorbid psychiatric emergency?

Step 2 — Risk stratify for PGD development in the first year:

Step 3 — Match treatment to disorder:

Step 4 — Reassess at defined intervals (2–4 weeks initially)

Avoid:

Pharmacotherapy — Evidence-Based Use and Limits

— HEAL trial (Shear et al., JAMA Psych 2016): citalopram did not improve PGD symptoms beyond Complicated Grief Therapy; CGT alone was as effective as CGT+citalopram for grief outcomes, though citalopram helped comorbid depressive symptoms

— Sertraline, escitalopram, paroxetine: no consistent benefit for grief-specific symptoms

— Comorbid MDD (PHQ-9 ≥10 with full criteria ≥2 weeks)

— Comorbid PTSD (sertraline, paroxetine are FDA-approved)

— Comorbid panic disorder, GAD, OCD

— Persistent suicidal ideation tied to depressive cognitions

— Sertraline 25–50 mg → titrate to 100–200 mg; preferred in elderly and cardiac patients

— Escitalopram 5–10 mg → 10–20 mg; clean drug-interaction profile

— Allow 4–6 weeks for effect; reassess PHQ-9

— Mirtazapine 15–30 mg qhs — useful when insomnia and weight loss dominate; sedating, appetite-stimulating

— Bupropion — avoid if anxiety prominent; useful when fatigue/anhedonia central

— Benzodiazepines — short-term sleep use only (≤2 weeks) if at all; risk of dependence, cognitive blunting, falls in elderly, paradoxical worsening of grief processing

— Atypical antipsychotics — not indicated unless psychotic features or severe agitation

— Hypnotics (z-drugs) — same fall/dependence concerns, prefer sleep hygiene and CBT-I

Board pearl: A widow at 8 months post-loss with insomnia and tearfulness who is otherwise functional does not need an SSRI or benzodiazepine — she needs psychoeducation, sleep hygiene, and follow-up. Reflexive prescribing is the wrong answer.

Core teaching: No medication is FDA-approved for grief or PGD. Pharmacotherapy targets comorbid psychiatric disorders, not grief per se.

Evidence base — what the trials showed:

When to prescribe an SSRI:

First-line SSRIs:

Second-line/adjunctive:

Medications to avoid:

Psychotherapy — First-Line Structured Interventions

— 16 weekly sessions, manualized, developed by Katherine Shear

— Core components: (1) psychoeducation about grief, (2) revisiting the death narrative (imaginal exposure), (3) situational revisiting (in vivo exposure to avoided places/activities), (4) aspirational goals work to rebuild future orientation, (5) memories and continuing bonds work, (6) imaginal conversation with the deceased

— RCT response rates ~70%, roughly double interpersonal therapy

— Cognitive restructuring of catastrophic loss-related beliefs ("Life is meaningless without him")

— Behavioral activation; exposure to avoided reminders

— Effective; often more accessible than CGT

— Evidence-based, expands access; appropriate for mild–moderate PGD

— "Grief" is one of IPT's four focal areas; effective for depression with bereavement but inferior to CGT for PGD-specific symptoms

— Psychoeducation: normalize waves, anniversary reactions, dual-process model

— Peer support groups (hospice bereavement programs, widow/widower groups, Compassionate Friends for child loss, survivors-of-suicide-loss groups)

— Chaplaincy and culturally congruent rituals

— Validate, do not pathologize; reflect that grief is the cost of love

— Schedule proactive follow-up rather than waiting for crisis

— Screen at 6 and 12 months post-loss

Step 3 management: When the question asks "most appropriate next step" for a patient meeting PGD criteria, refer to CGT/PGDT or grief-focused CBT — psychotherapy outranks pharmacotherapy as the answer.

Prolonged Grief Disorder Therapy (PGDT) / Complicated Grief Therapy (CGT) — the gold standard:

CBT for grief (Boelen and colleagues):

Internet-delivered CBT (iCBT) for grief:

Interpersonal Psychotherapy (IPT):

Supportive interventions (for normal grief, not PGD treatment):

Components of effective supportive care from primary care:

Special Populations — Elderly and Medical Comorbidity

— ~30% of widows/widowers experience clinically significant depressive symptoms in the first year

— Excess mortality in surviving spouse in first 6 months — "widowhood effect" — driven by cardiovascular events, suicide, and accidents

— Older bereaved men have the highest suicide rate of any demographic in the US

— Takotsubo cardiomyopathy ("broken heart syndrome") — apical ballooning, troponin elevation, normal coronaries; treat supportively, recovery within weeks

— Acute MI risk transiently increased after loss of close relative

— Sleep deprivation → falls, cognitive impairment that can mimic dementia

— Self-neglect: missed medications, dehydration, malnutrition — especially if deceased was the caregiver/cook

— Start SSRIs at half the usual dose (sertraline 25 mg, escitalopram 5 mg)

— Avoid paroxetine (anticholinergic, Beers list)

— Avoid TCAs (anticholinergic, orthostasis, cardiac conduction)

— Avoid benzodiazepines — Beers criteria, fall risk, delirium risk

— Monitor hyponatremia (SIADH) with SSRIs in elderly — check sodium at 2–4 weeks

— Sertraline and escitalopram are reasonable in CKD; both undergo hepatic metabolism — reduce dose in significant hepatic impairment

— Mirtazapine: dose reduce in moderate–severe renal or hepatic dysfunction

— Home safety evaluation, medication reconciliation, Meals on Wheels, senior centers, lethal means counseling (firearms, stockpiled medications)

Board pearl: The bereaved widower who "just isn't himself" 8 weeks after his wife's death — ask about firearm access and alcohol use before anything else. These two questions can save the patient's life and they are the right answer on the exam.

Bereavement is most common in older adults — spousal loss is a defining life event of late life.

Epidemiology:

Medical risks to monitor:

Pharmacotherapy adjustments:

Renal/hepatic:

Functional and social supports:

Special Populations — Children, Pregnancy, and Cultural Context

— DSM-5-TR PGD time threshold is ≥6 months (not 12) in those under 18

— Developmental presentation: regression (enuresis, clinginess), somatic complaints, school refusal, behavioral problems rather than verbalized sadness

— Children grieve in shorter, intermittent "bouts" — capacity for play does not indicate they are unaffected

— Magical thinking (preschool): may believe they caused the death; correct gently and concretely

— Adolescents: risk for substance use, self-harm, school decline

— Treatment: Trauma-Focused CBT for traumatic loss; family-based interventions; involve school counselors

— Allow age-appropriate participation in funeral rituals if the child wishes

— Disenfranchised grief — often minimized by society and providers

— Risk for PGD, MDD, PTSD; screen at postpartum visits

— Acknowledge the loss explicitly, use the baby's name if given, offer keepsakes, refer to perinatal bereavement programs

— Future pregnancy planning: address anxiety, recommend mental health support during subsequent pregnancy

— Sertraline preferred SSRI in pregnancy and lactation

— Avoid paroxetine (cardiac teratogenicity signal) and benzodiazepines (neonatal withdrawal, sedation)

— Mourning duration and expression vary widely: Jewish Shiva (7 days) and Sheloshim (30 days); Hindu 13-day mourning; Muslim 'iddah for widows (4 months 10 days); Latino Día de los Muertos continuing bonds

— Sustained communication with the deceased is normative in many cultures and not psychotic

— Do not pathologize culturally sanctioned practices; assess function and distress relative to the patient's own community norms

Key distinction: "Talking to my deceased husband at the altar each morning" in a culturally appropriate frame with preserved function is not PGD. The same behavior coupled with inability to work, eat, or care for grandchildren at 14 months is.

Children and adolescents:

Perinatal loss (miscarriage, stillbirth, neonatal death):

Pregnant/lactating bereaved women:

Cultural and religious considerations:

Complications and Adverse Outcomes

— Major depressive disorder — 50% of PGD patients meet criteria

— PTSD — especially after traumatic, violent, sudden, or witnessed death; suicide loss carries particularly high PTSD risk

— Substance use disorder — new or escalating alcohol, benzodiazepine, opioid use

— Suicidal ideation and completed suicide — independently elevated in PGD beyond comorbid depression

— Cardiovascular: MI risk transiently elevated ~21-fold in 24 hours post-loss, returning to baseline over months; takotsubo cardiomyopathy

— All-cause mortality: widowhood effect, peak first 6 months, more pronounced in men

— Immune dysregulation: increased infection risk, inflammatory markers

— Chronic pain worsening, somatic symptom amplification

— Sleep disorders: chronic insomnia in 40–70% of bereaved

— Weight loss/malnutrition, particularly in elderly

— Occupational disability — PGD predicts work absence at 12 and 24 months

— Social withdrawal and erosion of remaining relationships

— Financial harm from disability, impulsive decisions, or scams targeting bereaved

— Caregiving capacity loss — bereaved parent unable to attend to surviving children

— Benzodiazepine dependence after well-intentioned short-term prescribing

— Opioid escalation if pain and grief coexist

— Missed diagnoses (thyroid, anemia, cardiac) attributed to "just grief"

— Symptom recrudescence at anniversary of death, deceased's birthday, holidays — normal, time-limited, should be anticipated and discussed proactively

Board pearl: New-onset chest pain in a 65-year-old woman within days of her husband's death with apical ballooning on echo and normal coronaries is takotsubo cardiomyopathy — supportive care, beta-blocker, ACE inhibitor; ejection fraction typically recovers within weeks.

Psychiatric complications:

Medical complications:

Functional and social:

Iatrogenic complications:

Anniversary reactions:

When to Escalate Care — Triage Thresholds

— Active suicidal ideation with plan or intent, or recent attempt

— Homicidal ideation (rare but possible after suicide loss with blame attribution)

— Psychotic symptoms beyond transient grief hallucinations — sustained delusions, command auditory hallucinations

— Inability to maintain basic self-care, severe dehydration/malnutrition

— Catatonic features

— PGD with comorbid moderate-to-severe MDD or PTSD

— Passive suicidal ideation without plan but with risk factors (firearm access, alcohol use, prior attempt, isolation)

— Failure of first-line SSRI after 6–8 weeks

— Diagnostic uncertainty — is this PGD, complicated bereavement-related MDD, or PTSD?

— Confirmed PGD without comorbidity → grief-focused psychotherapist (CGT/PGDT-trained or grief-CBT)

— Stable comorbid depression on SSRI for ongoing therapy

— Palliative care/hospice bereavement services — many hospices offer 13 months of bereavement follow-up to family members of decedents at no charge; underutilized resource

— Social work for financial, housing, custody, and benefits navigation

— Chaplaincy/spiritual care when faith framework is central

— Primary care continues as medical home and care coordinator

— Imminent danger to self or others

— Grave disability

— Need for medication initiation under observation (e.g., severe MDD with high suicide risk)

CCS pearl: On a CCS case of a recently bereaved patient endorsing passive death wishes with a firearm at home, your orders should include: C-SSRS, suicide safety plan, lethal means counseling/firearm removal, same-day psychiatry consult, PHQ-9, AUDIT-C, social work consult, and scheduled follow-up in 1 week — do not simply prescribe and discharge.

Emergent psychiatric evaluation / ED referral:

Urgent outpatient psychiatry referral (days to 1–2 weeks):

Routine referral (weeks):

Consults to consider:

Hospitalization criteria (psychiatric):

Key Differentials — Within the Mood/Stress-Related Spectrum

— <12 months, wave-like, self-esteem preserved, function recovering

— ≥12 months (≥6 in youth), persistent yearning/preoccupation, identity disruption, functional impairment

— ≥2 weeks pervasive depressed mood or anhedonia plus neurovegetative symptoms

— Worthlessness/guilt is global, not focused on the deceased

— Anhedonia is pervasive, not relieved by positive memories or social contact

— Can be diagnosed during bereavement (no exclusion in DSM-5/DSM-5-TR)

— ≥2 years of low-grade depressed mood; predates the loss or extends well beyond

— Identifiable stressor (which can include loss), symptoms within 3 months, do not meet criteria for MDD/PGD, resolve within 6 months of stressor cessation

— Useful diagnosis for early post-loss distress that exceeds normal grief but is sub-threshold for other disorders

— Past hypomanic/manic episodes; loss can trigger an episode but the underlying disorder is bipolar

— Critical to identify before starting SSRI monotherapy (risk of switch)

— Trauma criterion met (witnessing violent death, learning of violent/accidental death of close one)

— Intrusions about the event, hyperarousal, avoidance of trauma cues, negative cognitions

— May coexist with PGD after traumatic loss

— Same trauma exposure, symptoms 3 days to 1 month post-event

Key distinction: PGD ≠ MDD ≠ PTSD, and they can coexist. Treat each component: CGT/PGDT for PGD, SSRI + psychotherapy for MDD, trauma-focused CBT or EMDR for PTSD. Step 3 will reward you for naming all three when criteria overlap.

Normal acute grief:

Prolonged Grief Disorder:

Major Depressive Disorder (with or without peripartum/seasonal/etc. specifier):

Persistent Depressive Disorder (dysthymia):

Adjustment disorder with depressed mood/anxiety/mixed:

Bipolar disorder, depressive episode:

PTSD:

Acute stress disorder:

Key Differentials — Medical and Other-Category Mimics

— Fatigue, weight gain, cold intolerance, constipation, depressed mood, slowed cognition

— Always check TSH in bereaved patient with depressive presentation

— Fatigue, pallor, cognitive slowing

— CBC, ferritin, B12, folate

— Common, contributes to fatigue and low mood

— Surviving spouse may have been "covering" cognitive decline; loss reveals it

— Screen with MoCA; consider workup for reversible causes

— Look for UTI, dehydration, medication effects (especially newly prescribed benzodiazepines or hypnotics)

— Alcohol use disorder commonly emerges or worsens; cannabis, opioid (often initially prescribed for "stress"), benzodiazepine misuse

— Withdrawal can mimic anxiety; intoxication can mimic depression

— Beta-blockers, interferon, isotretinoin, corticosteroids, varenicline — can cause depressive symptoms

— Opioids and benzodiazepines cause emotional blunting and depressive symptoms

— Diabetes, hyper-/hypocalcemia, adrenal insufficiency

— Often unmasked when bed partner dies; daytime fatigue, irritability, depressed mood

— Pancreatic cancer classically presents with depression preceding diagnosis

— Unexplained weight loss in bereaved patient warrants age-appropriate workup

Board pearl: Before attributing all symptoms to grief, complete a focused medical workup: TSH, CBC, CMP, B12, vitamin D, age-appropriate cancer screening, and a careful medication review. "Just grief" is a diagnosis of exclusion in patients with prominent neurovegetative or cognitive features.

Hypothyroidism:

Anemia (iron deficiency, B12, folate):

Vitamin D deficiency:

Neurocognitive disorder (dementia) unmasked by loss:

Delirium in elderly bereaved with acute confusion:

Substance use disorders:

Medication side effects:

Endocrine/metabolic:

Sleep apnea:

Malignancy:

Secondary Prevention and Long-Term Plan

— Targeted, not universal, preventive intervention — universal grief counseling has shown null effects and possible harm in low-risk individuals

— High-risk groups for proactive outreach: parents bereaved of a child, survivors of suicide loss, those bereaved by overdose, witnesses of traumatic death, those with prior psychiatric history or low social support

— Modalities: brief grief-focused CBT, hospice bereavement programs, peer support

— Maintenance psychotherapy or booster sessions as needed

— Continue SSRI for comorbid MDD/PTSD for at least 6–12 months after remission; first episode in older adults often warrants longer continuation

— Address ongoing anniversary reactions with anticipatory planning

— Regular sleep schedule, exercise (≥150 min/week moderate intensity), limited alcohol

— Restored social engagement: clubs, volunteering, faith community, support groups

— Re-engagement with meaning-making activities, future-oriented goals (PGDT framework)

— Optimize cardiovascular risk factors — bereaved patients are at elevated CV risk

— Blood pressure, lipids, diabetes screening per USPSTF

— Influenza, COVID, pneumococcal, shingles vaccines per schedule (stress-related immune effects)

— Lethal means restriction — firearms (off-site storage or sale), limit prescription stockpiles

— Written safety plan with warning signs, coping strategies, social contacts, crisis line (988)

— Encourage completion of own advance directives, will, healthcare proxy — bereavement often surfaces these gaps

Step 3 management: At 6- and 12-month post-loss visits, re-screen with PHQ-9, PG-13-R or BGQ, AUDIT-C, and C-SSRS, and reassess function. These visits are the highest-yield intervention points and should be on the problem list as scheduled visits, not opportunistic.

Prevention of PGD in high-risk bereaved:

Long-term management of PGD post-acute treatment:

Behavioral and lifestyle scaffolding:

Medical secondary prevention:

Safety planning:

Advance care and legacy:

Follow-Up, Monitoring, and Counseling

— 2 weeks after the loss for an in-person or telehealth check-in, especially in elders or high-risk patients

— 6 weeks, 3 months, 6 months, 12 months — protective scaffold across the first year

— Increased frequency around anniversaries, holidays, deceased's birthday

— More intensive cadence if on SSRI (2-week, 4-week, 8-week, then q3 months)

— PHQ-9 at each visit (depression burden)

— PG-13-R or BGQ at 6 and 12 months (PGD screen)

— C-SSRS if any positive PHQ-9 item 9 or expressed death wishes

— AUDIT-C at each visit

— Sleep, appetite, weight, social engagement, work/school functioning

— Medication adherence and side effects (SSRI: GI, sexual, hyponatremia in elderly, QTc with citalopram >40 mg or >20 mg in elderly)

— Normalize: "Grief is not a problem to solve; it's the cost of having loved."

— Educate on the dual-process model — oscillation between loss-oriented and restoration-oriented coping is healthy

— Warn against major life decisions in the first year if avoidable (selling the house, remarrying, quitting job)

— Encourage continuing bonds — memory boxes, rituals, letters to the deceased — these are healthy, not regressive

— Set expectations for anniversary reactions and holidays

— Graded return to work, hobbies, social roles

— Bereavement support groups; hospice bereavement programs (13 months free)

— Online communities (validated, moderated) — Modern Loss, The Dinner Party, GriefShare

— Acknowledge countertransference; debrief with colleagues; recognize compassion fatigue

CCS pearl: Order "schedule follow-up in 2 weeks" for an acutely bereaved patient and "schedule follow-up in 6 and 12 months" for longitudinal screening. The CCS engine rewards proactive scheduling over reactive management of grief trajectories.

Follow-up cadence (outpatient primary care):

Monitoring parameters:

Counseling content — what to say:

Rehabilitation and reintegration:

Caregiver self-care for clinicians:

Ethical, Legal, and Patient Safety Considerations

— DSM-5-TR PGD was controversial precisely because of concern that ordinary grief would be medicalized

— Clinicians must rigorously apply the 12-month threshold, symptom cluster, and functional impairment criteria before diagnosis

— Cultural humility is non-negotiable; some "abnormal" presentations are culturally normative

— Disclose lack of FDA approval for medications in grief and PGD

— Discuss psychotherapy as first-line for PGD with stronger evidence than medication

— Document discussion of SSRI risks (sexual dysfunction, hyponatremia, GI bleeding with NSAID co-use, withdrawal, black-box warning for suicidality in patients <25)

— Suicidal ideation with imminent risk → involuntary hold (state-specific statutes, e.g., 5150 in CA, Section 12 in MA) overrides confidentiality

— Tarasoff-type duty if specific identifiable threat to a third party (rare in grief but possible after suicide-loss blame attribution)

— Specifically ask about firearms, stockpiled medications, and access to lethal means

— Document discussion and disposition (off-site storage, gun lock, family safekeeping)

— Child neglect when bereaved parent is unable to care for surviving children — engage CPS only when safety threshold met; pair with support, not punishment

— Elder self-neglect — Adult Protective Services

— Bereaved patients discharged from inpatient psychiatry are at peak suicide risk in the first 30 days post-discharge — ensure follow-up appointment within 7 days, written safety plan, lethal means counseling, and warm handoff to outpatient provider

— Acute grief generally does not impair capacity, but assess case-by-case for major irreversible decisions (DNR changes, organ donation consent for deceased loved one)

Board pearl: The right answer to "what is the most important next step" for a bereaved patient with new SI and a firearm at home almost always includes lethal means counseling and securing the firearm before any prescription is written.

Pathologizing normal grief — primary ethical risk:

Informed consent and shared decision-making:

Confidentiality vs. duty to protect:

Lethal means counseling — patient safety best practice:

Mandatory reporting:

Transition-of-care risk (Step 3 high-yield):

Decision-making capacity:

High-Yield Associations and Rapid-Fire Facts

Step 3 management: The PGD vignette pattern is — 13–18 months post-loss + functional impairment + yearning + identity disruption → refer to grief-focused psychotherapy, not start an SSRI.

DSM-5-TR PGD time threshold: ≥12 months in adults, ≥6 months in children/adolescents

Core PGD symptoms: yearning/longing OR preoccupation with deceased + ≥3 of 8 (identity disruption, disbelief, avoidance, emotional pain, difficulty reintegrating, numbness, meaninglessness, loneliness)

First-line PGD treatment: Complicated Grief Therapy / Prolonged Grief Disorder Therapy (16 sessions)

Medication for grief itself: none FDA-approved; SSRIs treat comorbid MDD/PTSD, not grief

HEAL trial takeaway: citalopram did not add grief-specific benefit over CGT

Avoid: benzodiazepines (dependence, blunted processing, falls)

Highest-risk demographic for completed suicide post-loss: older men in first year of widowhood

Takotsubo cardiomyopathy: apical ballooning, post-emotional-stress, post-menopausal women, recovers spontaneously

Excess mortality "widowhood effect": peak first 6 months, mostly cardiovascular and suicide

DSM-5-TR removed the bereavement exclusion from MDD — MDD can be diagnosed during grief if criteria met ≥2 weeks

Transient hallucinations of the deceased in grief are normative across cultures — not psychosis

Hospice bereavement services: 13 months of follow-up to family of decedents, free, underused

Children: grieve in bouts, may regress, magical thinking causes self-blame in preschoolers; allow age-appropriate ritual participation

Perinatal loss: disenfranchised grief; acknowledge explicitly, use baby's name

Anniversary reactions: normal, anticipate proactively, do not pathologize

Continuing bonds: healthy expression — letters, rituals, memory boxes

Dual-process model: healthy oscillation between loss-orientation and restoration-orientation

Best screening tools: PG-13-R (specialty), BGQ (primary care), PHQ-9, GAD-7, PCL-5, C-SSRS, AUDIT-C

Crisis line: 988 Suicide and Crisis Lifeline

Highest-yield medical mimics: hypothyroidism, anemia, B12/D deficiency, sleep apnea, occult malignancy

Cultural normativity must be assessed before diagnosing PGD

Board Question Stem Patterns

— 6-week post-loss patient with sadness, intermittent tearfulness, intact function, brief auditory experience of hearing deceased's voice

— Answer: Normal acute grief. Reassurance, psychoeducation, scheduled follow-up. No SSRI, no benzodiazepine, no psychiatry referral.

— 14 months post-spouse-loss, still wearing wedding ring backwards on a chain, room untouched, hasn't returned to work, says "I don't know who I am without her," yearning daily

— Answer: Prolonged Grief Disorder; refer for Complicated Grief Therapy / PGDT.

— 8 weeks post-loss with pervasive anhedonia, worthlessness, weight loss, early-morning awakening, hopelessness about own future (not focused on deceased), PHQ-9 of 18

— Answer: MDD. Start sertraline + psychotherapy; assess SI.

— Mother witnessed teenage son die in MVC; 3 months later, nightmares of crash, avoidance of driving past intersection, hypervigilance

— Answer: PTSD. Trauma-focused CBT ± sertraline/paroxetine.

— Elderly widower, alcohol use up, firearm in home, says "I'd like to be with her"

— Answer: Safety planning, lethal means counseling/firearm removal, urgent psychiatric evaluation.

— Post-menopausal woman with chest pain hours after husband's sudden death, troponin mildly elevated, ECG ST changes, cath shows clean coronaries, apical ballooning on echo

— Answer: Takotsubo cardiomyopathy; supportive care, beta-blocker + ACEi, recovery in weeks.

— Acutely bereaved patient with insomnia — wrong answers: alprazolam, zolpidem long-term, paroxetine in elder. Right: sleep hygiene, CBT-I, short-term low-dose trazodone if needed, follow-up.

— Patient observing extended mourning ritual congruent with their faith, maintaining function

— Answer: Normal; do not pathologize.

Key distinction: When the stem gives a 12+ month timeline, yearning, and identity disruption, the answer is psychotherapy referral. When the stem gives <12 months with full MDD criteria, the answer is SSRI + therapy. When the stem gives trauma intrusions about the death event, the answer is trauma-focused therapy.

Pattern 1 — The "is this normal?" stem:

Pattern 2 — The PGD diagnosis stem:

Pattern 3 — The MDD-during-bereavement stem:

Pattern 4 — The PTSD-after-traumatic-loss stem:

Pattern 5 — The suicide-risk stem:

Pattern 6 — The takotsubo stem:

Pattern 7 — The wrong-prescription distractor:

Pattern 8 — The cultural-context stem:

One-Line Recap

Grief is the normative response to bereavement, while Prolonged Grief Disorder is a DSM-5-TR diagnosis requiring persistent yearning or preoccupation with identity disruption and functional impairment ≥12 months after the loss (≥6 in youth), treated first-line with grief-focused psychotherapy (CGT/PGDT) — not antidepressants — while comorbid MDD, PTSD, and substance use disorders are screened for and treated on their own merits.

Board pearl: When in doubt between "start an SSRI" and "refer for grief therapy" in a patient meeting PGD criteria without comorbid MDD or PTSD, choose grief therapy — that is the Step 3-aligned, evidence-based, exam-correct answer.

Diagnose PGD by time + phenotype + function: ≥12 months, yearning/preoccupation + ≥3 of 8 grief features, clinically significant impairment beyond cultural norms — not by intensity of sadness alone.

Treat PGD with psychotherapy first: Complicated Grief Therapy or Prolonged Grief Disorder Therapy is the gold standard; SSRIs are reserved for comorbid MDD/PTSD, where sertraline or escitalopram are preferred and benzodiazepines are avoided.

Always screen for suicide, substance use, and medical mimics: bereaved older men with firearm access are the highest-risk subgroup; check TSH, CBC, B12, vitamin D, and screen with PHQ-9, PG-13-R, C-SSRS, and AUDIT-C; remember takotsubo cardiomyopathy and the first-6-month widowhood mortality bump.

Schedule proactive follow-up: 2 weeks, 6 weeks, 3, 6, and 12 months post-loss with re-screening; engage hospice bereavement programs, peer support, and lethal means counseling; respect cultural mourning practices and continuing bonds as healthy expressions — pathologize only when criteria, distress, and impairment converge.